Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance.
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance.
复制标题
DOI:
10.1016/j.atherosclerosis.2012.10.035
复制
发表时间:
2013-01
期刊:
影响因子:
5.3
通讯作者:
Trischitta V
中科院分区:
文献类型:
--
作者:
Bacci S;Prudente S;Copetti M;Spoto B;Rizza S;Baratta R;Di Pietro N;Morini E;Di Paola R;Testa A;Mallamaci F;Tripepi G;Zhang YY;Mercuri L;Di Silvestre S;Lauro R;Malatino L;Consoli A;Pellegrini F;Pandolfi A;Frittitta L;Zoccali C;Federici M;Doria A;Trischitta V
Insulin resistance (IR) and cardiovascular disease (CVD) share a common soil. We investigated the combined role of single nucleotide polymorphisms (SNPs) affecting insulin signaling (ENPP1 K121Q, rs1044498; IRS1 G972R, rs1801278; TRIB3 Q84R, rs2295490) on CVD, age at myocardial infarction (MI), in vivo insulin sensitivity and in vitro insulin-stimulated nitric oxide synthase (NOS) activity. 1. We first studied, incident cardiovascular events (a composite endpoint comprising myocardial infarction -MI-, stroke and cardiovascular death) in 733 patients (2,186 person-years, 175 events). 2. In a replication attempt, age at MI was tested in 331 individuals. 3. OGTT-derived insulin sensitivity index (ISI) was assessed in 829 individuals with fasting glucose < 126 mg/dl. 4. NOS activity was measured in 40 strains of human vein endothelial cells (HUVECs). 1. Risk variants jointly predicted cardiovascular events (HR=1.181; p=0.0009) and, when added to clinical risk factors, significantly improved survival C-statistics; they also allowed a significantly correct reclassification (by net reclassification index) in the whole sample (135/733 individuals) and, even more, in obese patients (116/204 individuals). 2. Risk variants were jointly associated with age at MI (p=0.006). 3. A significant association was also observed with ISI (p=0.02). 4. Finally, risk variants were jointly associated with insulin-stimulated NOS activity in HUVECs (p=0.009). Insulin signaling genes variants jointly affect cardiovascular disease, very likely by promoting whole body and endothelium-specific insulin resistance. Further studies are needed to address whether their genotyping help identify very high-risk patients who need specific and/or more aggressive preventive strategies.
登录
查看更多内容
DOI:
10.1056/nejmoa072366
发表时间:
2007-08-02
期刊:
The New England journal of medicine
影响因子:
--
作者:
Samani NJ;Erdmann J;Hall AS;Hengstenberg C;Mangino M;Mayer B;Dixon RJ;Meitinger T;Braund P;Wichmann HE;Barrett JH;König IR;Stevens SE;Szymczak S;Tregouet DA;Iles MM;Pahlke F;Pollard H;Lieb W;Cambien F;Fischer M;Ouwehand W;Blankenberg S;Balmforth AJ;Baessler A;Ball SG;Strom TM;Braenne I;Gieger C;Deloukas P;Tobin MD;Ziegler A;Thompson JR;Schunkert H;WTCCC and the Cardiogenics Consortium
通讯作者:
WTCCC and the Cardiogenics Consortium
影响因子:
168.9
作者:
CLAUSEN, JO;HANSEN, T;PEDERSEN, O
通讯作者:
PEDERSEN, O
影响因子:
8.8
作者:
Berg, Alfred O.;Botkin, Jeffrey;Veenstra, David L.
通讯作者:
Veenstra, David L.
影响因子:
7.7
作者:
Rich, SS;Bowden, DW;Bergmans, RN
通讯作者:
Bergmans, RN
影响因子:
15.9
作者:
Liew, Chong Wee;Bochenski, Jacek;Kulkarni, Rohit N.
通讯作者:
Kulkarni, Rohit N.